Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
283.95
+9.81 (3.58%)
At close: Jan 15, 2026, 4:00 PM EST
283.88
-0.07 (-0.02%)
After-hours: Jan 15, 2026, 7:14 PM EST
Humana Market Cap
Humana has a market cap or net worth of $34.15 billion as of January 15, 2026. Its market cap has increased by 10.95% in one year.
Market Cap
34.15B
Enterprise Value
41.71B
1-Year Change
10.95%
Ranking
Category
Stock Price
$283.95
Market Cap Chart
Since December 1, 1998, Humana's market cap has increased from $3.36B to $34.15B, an increase of 917.11%. That is a compound annual growth rate of 8.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 32.97B | 7.03% |
| Dec 31, 2025 | 30.81B | 0.84% |
| Dec 31, 2024 | 30.55B | -45.80% |
| Dec 29, 2023 | 56.36B | -13.08% |
| Dec 30, 2022 | 64.84B | 8.76% |
| Dec 31, 2021 | 59.62B | 9.81% |
| Dec 31, 2020 | 54.30B | 11.87% |
| Dec 31, 2019 | 48.54B | 23.50% |
| Dec 31, 2018 | 39.30B | 10.90% |
| Dec 29, 2017 | 35.44B | 16.50% |
| Dec 30, 2016 | 30.42B | 14.97% |
| Dec 31, 2015 | 26.46B | 20.14% |
| Dec 31, 2014 | 22.02B | 36.85% |
| Dec 31, 2013 | 16.09B | 48.20% |
| Dec 31, 2012 | 10.86B | -24.19% |
| Dec 30, 2011 | 14.32B | 55.47% |
| Dec 31, 2010 | 9.21B | 23.61% |
| Dec 31, 2009 | 7.45B | 18.51% |
| Dec 31, 2008 | 6.29B | -50.71% |
| Dec 31, 2007 | 12.76B | 38.78% |
| Dec 29, 2006 | 9.19B | 3.96% |
| Dec 30, 2005 | 8.84B | 86.87% |
| Dec 31, 2004 | 4.73B | 28.57% |
| Dec 31, 2003 | 3.68B | 122.75% |
| Dec 31, 2002 | 1.65B | -16.91% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.08B |
| Johnson & Johnson | 523.06B |
| AbbVie | 383.06B |
| UnitedHealth Group | 300.45B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 271.66B |
| Novo Nordisk | 262.20B |